Anne Fuhlbrigge, MD

One of the more common and serious lung conditions among older adults worldwide, chronic obstructive pulmonary disease (COPD) is associated with chronic inflammation.  The majority of cases of COPD are caused by exposure to tobacco smoke, but there are some other exposure factors that may contribute to the development of COPD, including indoor and outdoor air pollution and industrial chemicals.

In this video, Dr. Anne Fuhlbrigge, Clinical Director of the Division of Pulmonary and Critical Care Medicine, discusses current COPD treatment and new therapies being studied. “Earlier identification and treatment for COPD, along with management of other health conditions, are important for improving outcomes of patients with COPD,” says Dr. Fuhlbrigge.

Related links:

– Jessica F.

comments (0)